Anthony Hunt, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 90,702 shares at $146.85 ($13.4M) on 2020-09-10, disclosed to the SEC on 2020-09-14.
Open-market sale of $13.4M RGEN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $146.85 | 4,856 | $713K | 5.3% |
| 2 | $146.85 | 4,856 | $713K | 5.3% |
| 3 | $147.68 | 11,132 | $1.6M | 12.2% |
| 4 | $147.68 | 11,132 | $1.6M | 12.2% |
| 5 | $148.56 | 26,966 | $4.0M | 29.8% |
| 6 | $148.56 | 26,966 |
| $4.0M |
| 29.8% |
| 7 | $149.30 | 2,397 | $358K | 2.7% |
| 8 | $149.30 | 2,397 | $358K | 2.7% |
| Total | $148.20 avg | 90,702 | $13.4M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |